News

Medically reviewed by Femi Aremu, PharmD Ozempic and Wegovy are both glucagon-like peptide-1 (GLP-1) receptor agonists and ...
The maker of Ozempic and Wegovy expects lower sales and profit growth this year despite recent victories against compounders.